Logo image of PED

PEDEVCO CORP (PED) Stock Fundamental Analysis

NYSEARCA:PED - NYSE Arca - US70532Y3036 - Common Stock - Currency: USD

0.5992  -0.02 (-3.35%)

After market: 0.6202 +0.02 (+3.5%)

Fundamental Rating

5

Overall PED gets a fundamental rating of 5 out of 10. We evaluated PED against 208 industry peers in the Oil, Gas & Consumable Fuels industry. PED has an average financial health and profitability rating. PED has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
In the past year PED had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PED reported negative net income in multiple years.
Each year in the past 5 years PED had a positive operating cash flow.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

PED's Return On Assets of 11.78% is amongst the best of the industry. PED outperforms 87.50% of its industry peers.
PED has a better Return On Equity (14.10%) than 69.71% of its industry peers.
PED's Return On Invested Capital of 2.81% is on the low side compared to the rest of the industry. PED is outperformed by 67.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PED is significantly below the industry average of 23.52%.
Industry RankSector Rank
ROA 11.78%
ROE 14.1%
ROIC 2.81%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

PED's Profit Margin of 42.71% is amongst the best of the industry. PED outperforms 91.83% of its industry peers.
PED has a Operating Margin (11.38%) which is in line with its industry peers.
Looking at the Gross Margin, with a value of 66.82%, PED is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
PED's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.38%
PM (TTM) 42.71%
GM 66.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PED is destroying value.
The number of shares outstanding for PED has been increased compared to 1 year ago.
The number of shares outstanding for PED has been increased compared to 5 years ago.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that PED is in the distress zone and has some risk of bankruptcy.
PED has a Altman-Z score of 0.85. This is comparable to the rest of the industry: PED outperforms 42.31% of its industry peers.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.31
WACC8.97%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.40 indicates that PED should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, PED is in the better half of the industry, outperforming 63.94% of the companies in the same industry.
A Quick Ratio of 1.40 indicates that PED should not have too much problems paying its short term obligations.
PED has a better Quick ratio (1.40) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 223.33% over the past year.
Looking at the last year, PED shows a very strong growth in Revenue. The Revenue has grown by 30.69%.
PED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.98% yearly.
EPS 1Y (TTM)223.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)30.69%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%7.64%

3.2 Future

PED is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -36.44% yearly.
PED is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.26% yearly.
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.27%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.15 indicates a rather cheap valuation of PED.
PED's Price/Earnings ratio is rather cheap when compared to the industry. PED is cheaper than 98.08% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.87, PED is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.42, the valuation of PED can be described as very cheap.
77.88% of the companies in the same industry are more expensive than PED, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PED to the average of the S&P500 Index (35.34), we can say PED is valued rather cheaply.
Industry RankSector Rank
PE 3.15
Fwd PE 7.42
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PED is valued cheaply inside the industry as 93.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.27
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as PED's earnings are expected to decrease with -36.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PED!.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (8/15/2025, 8:04:01 PM)

After market: 0.6202 +0.02 (+3.5%)

0.5992

-0.02 (-3.35%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-18 2025-08-18
Inst Owners2.68%
Inst Owner Change-0.36%
Ins Owners71.72%
Ins Owner Change0%
Market Cap55.02M
Analysts80
Price Target1.86 (210.41%)
Short Float %0.53%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)602.98%
Min EPS beat(2)-73.6%
Max EPS beat(2)1279.56%
EPS beat(4)3
Avg EPS beat(4)330.55%
Min EPS beat(4)-73.6%
Max EPS beat(4)1279.56%
EPS beat(8)3
Avg EPS beat(8)146.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.87%
Min Revenue beat(2)-4.95%
Max Revenue beat(2)12.69%
Revenue beat(4)3
Avg Revenue beat(4)6.64%
Min Revenue beat(4)-4.95%
Max Revenue beat(4)17.66%
Revenue beat(8)6
Avg Revenue beat(8)7.09%
Revenue beat(12)7
Avg Revenue beat(12)4.43%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.57%
Revenue NY rev (1m)-9.73%
Revenue NY rev (3m)-9.73%
Valuation
Industry RankSector Rank
PE 3.15
Fwd PE 7.42
P/S 1.37
P/FCF N/A
P/OCF 2.39
P/B 0.45
P/tB 0.45
EV/EBITDA 2.27
EPS(TTM)0.19
EY31.71%
EPS(NY)0.08
Fwd EY13.48%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.25
OCFY41.78%
SpS0.44
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 14.1%
ROCE 3.55%
ROIC 2.81%
ROICexc 3.05%
ROICexgc 3.05%
OM 11.38%
PM (TTM) 42.71%
GM 66.82%
FCFM N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)3.72%
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 178.98%
Cap/Sales 70.92%
Interest Coverage 250
Cash Conversion 112.2%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 0.85
F-Score7
WACC8.97%
ROIC/WACC0.31
Cap/Depr(3y)201.19%
Cap/Depr(5y)159.31%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)223.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.69%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%7.64%
Revenue Next Year-15.27%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.69%
OCF growth 3Y28.83%
OCF growth 5Y50.2%